Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient’s Activity Level
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient’s Activity Level
Authors
Keywords
-
Journal
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
Volume -, Issue -, Pages 120347542110035
Publisher
SAGE Publications
Online
2021-03-29
DOI
10.1177/12034754211003525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series
- (2020) Muge G. Ozden et al. Dermatologic Therapy
- Characteristics, risk factors and treatment reality in livedoid vasculopathy – a multicentre analysis
- (2019) C. Weishaupt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Thromboembolic risk with IVIg
- (2019) Mahima Kapoor et al. NEUROLOGY
- Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options
- (2018) E Gardette et al. ACTA DERMATO-VENEREOLOGICA
- Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis
- (2017) R. Renner et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs
- (2016) Eric M. Ammann et al. AMERICAN JOURNAL OF HEMATOLOGY
- European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology
- (2016) Alexander Enk et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
- (2016) Carsten Weishaupt et al. Lancet Haematology
- Efficacy of intravenous immunoglobulins in livedoid vasculopathy: Long-term follow-up of 11 patients
- (2014) Babak Monshi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Quality-of-life impairment in patients with livedoid vasculopathy
- (2014) Maria Rita Polo Gascón et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: Results from a retrospective cohort study
- (2014) Elena Ramírez et al. THROMBOSIS RESEARCH
- Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review
- (2013) Touda Bounfour et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Livedoid vasculopathy as a coagulation disorder
- (2010) Paulo Ricardo Criado et al. AUTOIMMUNITY REVIEWS
- Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study
- (2010) TB Di Giacomo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started